MENU

MLYS Mineralys Therapeutics Forecast, Technical & Fundamental Analysis

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone... Show more

MLYS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
MLYS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MLYS is expected to report earnings to fall 73.68% to -75 cents per share on November 16

Mineralys Therapeutics MLYS Stock Earnings Reports
Q3'26
Est.
$-0.75
Q2'26
Missed
by $0.22
Q1'26
Beat
by $0.34
Q4'25
Beat
by $0.54
Q3'25
Beat
by $0.44
The last earnings report on August 11 showed earnings per share of -284 cents, missing the estimate of -263 cents. With 640.07K shares outstanding, the current market capitalization sits at 2.29B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
76
Web
https://mineralystx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GINX36.210.26
+0.72%
SGI Enhanced Global Income ETF (GINX)
ZTEN47.980.01
+0.03%
F/M 10-Year Investment Grade Corporate Bond ETF (ZTEN)
HAP74.74N/A
N/A
VanEck Natural Resources ETF (HAP)
PCR18.20-0.05
-0.29%
Simplify VettaFi Private Credit Strategy ETF (PCR)
ASHR33.09-0.10
-0.30%
Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)

MLYS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with NKTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-2.75%
NKTX - MLYS
41%
Loosely correlated
-3.51%
COGT - MLYS
40%
Loosely correlated
+2.80%
ROIV - MLYS
39%
Loosely correlated
-0.91%
DNLI - MLYS
39%
Loosely correlated
-0.39%
BCYC - MLYS
38%
Loosely correlated
-1.21%
More
Mineralys Therapeutics (MLYS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com